Oval Medical Technologies

Delivering superior single-use subcutaneous and intramuscular autoinjector platforms that are patient centric with the potential to confer clinical advantages.

Oval Medical Technologies is dedicated to bringing the best patient centric, single use, autoinjector platforms to the global market.

Oval’s approach to device development combines a deep understanding of patient need with advance autoinjection technology, allowing customization of platforms and the creation of devices that work for any patient or formulation.

Oval platforms address:

  • Fragile formulations
  • Viscous formulations
  • Non-Newtonian characteristics
  • Delivery volumes up to 3ml
  • Subcutaneous injection
  • Intramuscular injection

Combination device opportunities include:

  • Epinephrine autoinjector for anaphylactic shock that is ultra-portable and easy to use
  • Sumatriptan autoinjector for cluster headaches and migraine attacks to make patient lives simpler

Case Study

input search string and hit enter